Am J Cardiol

1. KOTINI-SHAH P, Duran-Luciano P, Kansal M, Nasrollahi F, et al
   Global Longitudinal Strain Reference Values in the Hispanic/Latino Population: Echocardiographic Study of Latinos (ECHO-SOL).
   Am J Cardiol. 2026;261:41-49.
   

   >> Share

   
   

   
   Circ Heart Fail

2. TRINKLEY KE, Glasgow RE
   From Automation to Action in Heart Failure: Digital Solutions, Pragmatic Evidence, and the Integrative Role of Implementation Science.
   Circ Heart Fail. 2026 Jan 29:e013900. doi: 10.1161/CIRCHEARTFAILURE.125.013900.
   

   >> Share

   
   
3. BUTT JH, Henderson AD, Jhund PS, Claggett BL, et al
   Finerenone, Liver Biomarkers, and Heart Failure With Mildly Reduced/Preserved Ejection Fraction: An Analysis of FINEARTS-HF.
   Circ Heart Fail. 2026 Jan 29:e013201. doi: 10.1161/CIRCHEARTFAILURE.125.013201.
   

   >> Share

   
   
4. VIDULA MK, Schurgers LJ, Zhao L, Dib MJ, et al
   Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure.
   Circ Heart Fail. 2026 Jan 28:e012734. doi: 10.1161/CIRCHEARTFAILURE.124.012734.
   

   >> Share

   
   

   
   Eur Heart J

5. EMANUELSSON F, Benn M
   GLP-1 receptor agonists and heart failure: insights from human genetics.
   Eur Heart J. 2026 Jan 29:ehaf1058. doi: 10.1093/eurheartj/ehaf1058.
   

   >> Share

   
   
6. HU Y, Zhao Y, Dai N, Zhou Y, et al
   GLP-1R agonists and heart failure: novel beneficial effects suggested by Mendelian randomization.
   Eur Heart J. 2026 Jan 29:ehaf1066. doi: 10.1093/eurheartj/ehaf1066.
   

   >> Share

   
   

   
   Hypertension

7. WASSENAAR JW, Smart CD, Fehrenbach DJ, Shuey MM, et al
   Galectin-1 Is a Marker but Not a Mediator of Heart Failure With Preserved Ejection Fraction.
   Hypertension. 2026 Jan 30. doi: 10.1161/HYPERTENSIONAHA.125.26006.
   

   >> Share

   
   

   
   Int J Cardiol

8. SUN Q, Xu Y, Tan W, Yao Z, et al
   Leveraging explainable machine learning models to predict moderate to severe obstructive sleep apnea in heart failure with preserved ejection fraction patients: A comorbidity perspective.
   Int J Cardiol. 2026;444:133993.
   

   >> Share

   
   
9. ZUIN M, Vitali F, Canovi L, Serenelli M, et al
   SGLT2 inhibitors and risk of new-onset left bundle branch block in heart failure with preserved ejection fraction.
   Int J Cardiol. 2026 Jan 22:134190. doi: 10.1016/j.ijcard.2026.134190.
   

   >> Share

   
   

   
   J Card Fail

10. CAJITA M, Peters L, Rao VN, Kitsiou S, et al
    Integrated Health Technologies in Heart Failure: A Scientific Statement From the Heart Failure Society of America and the American Association of Heart Failure Nurses.
    J Card Fail. 2026 Jan 27:S1071-9164(25)01036.
    

    >> Share

    
    
11. KHAN MS, Rashid AM, Collins SP, Petrie MC, et al
    "Readiness for Discharge" as a Novel Endpoint in Heart Failure Trials.
    J Card Fail. 2026 Jan 24:S1071-9164(26)00032.
    

    >> Share

    
    
12. MANN DL, Chirinos JA, Yu J, Yang W, et al
    Circulating Proteomic Profiles in Ambulatory Patients With Advanced Stage C2D Heart Failure: Insights From the REVIVAL Registry.
    J Card Fail. 2026 Jan 22:S1071-9164(26)00029.
    

    >> Share

    
    

    
    J Cardiol

13. CETIN T
    Letter to the editor: Biomarker-based pre-heart failure screening in a middle-aged rural population.
    J Cardiol. 2026 Jan 26:S0914-5087(26)00015-8. doi: 10.1016/j.jjcc.2026.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share